Table 2 Association between circulating miR-1290 expression and clinicopathologic characteristics in 46 pancreatic cancer patients

Age (year)

65.48 ± 1.77

69.15 ± 3.53

64.03 ± 2.01

Sex

 Male

32

9

23

 Female

14

4

10

BMI (kg/m²)

22.01 (19.69–25.40)

23.26 (20.00–26.88)

21.97 (19.16–25.13)

Smoke

 Yes

17

2

15

 No

29

11

18

Alcohol

 Yes

14

2

12

 No

32

11

21

Hypertension

 Yes

20

6

14

 No

26

7

19

Diabetes

 Yes

13

4

9

 No

33

9

24

Location

 Head

29

8

21

 Body and tail

17

5

12

Tumor size (cm)

3.55 (2.32–4.53)

2.30 (1.80–2.80)

4.00 (2.87–4.60)

Lymphatic invasion

 Positive

35

6

29

 Negative

11

7

4

Venous invasion

 Positive

32

6

26

 Negative

14

7

7

Distant metastasis

 Positive

23

3

20

 Negative

23

10

13

Differentiation

 Well

7

3

4

 Moderate

22

9

13

Poor

17

1

16

TNM stage (AJCC)

 I and II

23

10

13

 III and IV

23

3

20

CRP (mg/l)

 < 10

33

10

23

 ≥ 10

13

3

10

CEA (ng/ml)

 < 5

30

10

20

 ≥ 5

16

3

13

CA199 (U/ml)

 < 37

6

2

4

 ≥ 37

40

11

29

CA125 (U/ml)

 < 35

24

9

15

 ≥ 35

22

4

18

CA242 (U/ml)

 < 20

16

4

12

 ≥ 20

30

9

21

CA211 (ng/ml)

 < 5

34

11

23

 ≥ 5

12

2

10